Overweight and obesity in 5- to 6-year-old schoolchildren in Switzerland from 2003 to 2018.


Journal

Swiss medical weekly
ISSN: 1424-3997
Titre abrégé: Swiss Med Wkly
Pays: Switzerland
ID NLM: 100970884

Informations de publication

Date de publication:
27 Jul 2020
Historique:
entrez: 18 8 2020
pubmed: 18 8 2020
medline: 19 8 2021
Statut: epublish

Résumé

Overweight and obesity in children and the harmful health consequences of these conditions throughout the course of their lives is a growing, worldwide public health problem. The purpose of this study is to evaluate the evolution of the prevalence of being overweight and obese among 5- to 6-year-old schoolchildren in Geneva from 2003 to 2018, and to compare it to other areas of Switzerland. A cross-sectional study at nine points in time, conducted in public schools from 2003–2004 to 2017–2018. During a systematic health check at school, data on the height and body weight of 5- to 6-year-old children attending public schools in the canton of Geneva were obtained. 12,918 girls and 13,395 boys were recruited for the study. Cole’s references were used to classify the body mass index. In 2017–18 the combined prevalence of overweight and obesity was 14.6%, of which 10.3% were overweight (14.5% for girls and 5.9% for boys) and 4.3% were obese (4.5% for girls and 4.2% for boys). For girls, we observed a non-significant increase in the prevalence of overweight of 2.5 points (p = 0.14) between 2003–04 and 2017–18, as opposed to boys, where we observed a non-significant downward trend (−2.7 points, p = 0.06) over the same period. A relatively marked and statistically significant increase in the prevalence of obesity (1.9 points, p = 0.0130) since 2010 was observed for both sexes in this age group. From 2003 to 2018 we observed a stabilisation in the prevalence of overweight and obesity in childhood, which is consistent with results from other Swiss cities, as well as in some other countries worldwide. The significant increase in obesity observed since 2010 will have to be monitored and justifies pursuing public health policies and potentially some more aggressive approaches.

Identifiants

pubmed: 32799306
doi: 10.4414/smw.2020.20309
pii: Swiss Med Wkly. 2020;150:w20309
doi:
pii:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

w20309

Auteurs

Luisa F Narvaez (LF)

Institute of Global Health, Faculty of Medicine, University of Geneva, Switzerland.

Per Mahler (P)

Service de santé de la jeunesse, Département de l'instruction publique, Geneva, Switzerland.

Lynne Thadikkaran-Salomon (L)

Cantonal Health Service, General Directorate for Health, Geneva, Switzerland.

Emilien Jeannot (E)

Institute of Global Health, Faculty of Medicine, University of Geneva, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH